1 Fibrin Sealant (Human) Market Overview 1.1 Product Overview and Scope of Fibrin Sealant (Human) 1.2 Fibrin Sealant (Human) Segment by Type 1.2.1 Global Fibrin Sealant (Human) Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 2mL/Set 1.2.3 4mL/Set 1.2.4 10mL/Set 1.3 Fibrin Sealant (Human) Segment by Application 1.3.1 Fibrin Sealant (Human) Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Global Fibrin Sealant (Human) Market Size Estimates and Forecasts 1.4.1 Global Fibrin Sealant (Human) Revenue 2016-2027 1.4.2 Global Fibrin Sealant (Human) Sales 2016-2027 1.4.3 Fibrin Sealant (Human) Market Size by Region: 2016 Versus 2021 Versus 2027 2 Fibrin Sealant (Human) Market Competition by Manufacturers 2.1 Global Fibrin Sealant (Human) Sales Market Share by Manufacturers (2016-2021) 2.2 Global Fibrin Sealant (Human) Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Fibrin Sealant (Human) Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Fibrin Sealant (Human) Manufacturing Sites, Area Served, Product Type 2.5 Fibrin Sealant (Human) Market Competitive Situation and Trends 2.5.1 Fibrin Sealant (Human) Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Fibrin Sealant (Human) Players Market Share by Revenue 2.5.3 Global Fibrin Sealant (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Fibrin Sealant (Human) Retrospective Market Scenario by Region 3.1 Global Fibrin Sealant (Human) Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Fibrin Sealant (Human) Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Fibrin Sealant (Human) Market Facts & Figures by Country 3.3.1 North America Fibrin Sealant (Human) Sales by Country 3.3.2 North America Fibrin Sealant (Human) Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Fibrin Sealant (Human) Market Facts & Figures by Country 3.4.1 Europe Fibrin Sealant (Human) Sales by Country 3.4.2 Europe Fibrin Sealant (Human) Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Fibrin Sealant (Human) Market Facts & Figures by Region 3.5.1 Asia Pacific Fibrin Sealant (Human) Sales by Region 3.5.2 Asia Pacific Fibrin Sealant (Human) Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Fibrin Sealant (Human) Market Facts & Figures by Country 3.6.1 Latin America Fibrin Sealant (Human) Sales by Country 3.6.2 Latin America Fibrin Sealant (Human) Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Fibrin Sealant (Human) Market Facts & Figures by Country 3.7.1 Middle East and Africa Fibrin Sealant (Human) Sales by Country 3.7.2 Middle East and Africa Fibrin Sealant (Human) Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Fibrin Sealant (Human) Historic Market Analysis by Type 4.1 Global Fibrin Sealant (Human) Sales Market Share by Type (2016-2021) 4.2 Global Fibrin Sealant (Human) Revenue Market Share by Type (2016-2021) 4.3 Global Fibrin Sealant (Human) Price by Type (2016-2021) 5 Global Fibrin Sealant (Human) Historic Market Analysis by Application 5.1 Global Fibrin Sealant (Human) Sales Market Share by Application (2016-2021) 5.2 Global Fibrin Sealant (Human) Revenue Market Share by Application (2016-2021) 5.3 Global Fibrin Sealant (Human) Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Baxter 6.1.1 Baxter Corporation Information 6.1.2 Baxter Description and Business Overview 6.1.3 Baxter Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Baxter Product Portfolio 6.1.5 Baxter Recent Developments/Updates 6.2 CSL 6.2.1 CSL Corporation Information 6.2.2 CSL Description and Business Overview 6.2.3 CSL Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2016-2021) 6.2.4 CSL Product Portfolio 6.2.5 CSL Recent Developments/Updates 6.3 Bayer 6.3.1 Bayer Corporation Information 6.3.2 Bayer Description and Business Overview 6.3.3 Bayer Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Bayer Product Portfolio 6.3.5 Bayer Recent Developments/Updates 6.4 Grifols 6.4.1 Grifols Corporation Information 6.4.2 Grifols Description and Business Overview 6.4.3 Grifols Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Grifols Product Portfolio 6.4.5 Grifols Recent Developments/Updates 6.5 Octapharma 6.5.1 Octapharma Corporation Information 6.5.2 Octapharma Description and Business Overview 6.5.3 Octapharma Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Octapharma Product Portfolio 6.5.5 Octapharma Recent Developments/Updates 6.6 Shanghai RAAS 6.6.1 Shanghai RAAS Corporation Information 6.6.2 Shanghai RAAS Description and Business Overview 6.6.3 Shanghai RAAS Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Shanghai RAAS Product Portfolio 6.6.5 Shanghai RAAS Recent Developments/Updates 6.7 Hualan Biological 6.6.1 Hualan Biological Corporation Information 6.6.2 Hualan Biological Description and Business Overview 6.6.3 Hualan Biological Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Hualan Biological Product Portfolio 6.7.5 Hualan Biological Recent Developments/Updates 6.8 Immuno 6.8.1 Immuno Corporation Information 6.8.2 Immuno Description and Business Overview 6.8.3 Immuno Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Immuno Product Portfolio 6.8.5 Immuno Recent Developments/Updates 6.9 Behringwerke 6.9.1 Behringwerke Corporation Information 6.9.2 Behringwerke Description and Business Overview 6.9.3 Behringwerke Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Behringwerke Product Portfolio 6.9.5 Behringwerke Recent Developments/Updates 7 Fibrin Sealant (Human) Manufacturing Cost Analysis 7.1 Fibrin Sealant (Human) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Fibrin Sealant (Human) 7.4 Fibrin Sealant (Human) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Fibrin Sealant (Human) Distributors List 8.3 Fibrin Sealant (Human) Customers 9 Fibrin Sealant (Human) Market Dynamics 9.1 Fibrin Sealant (Human) Industry Trends 9.2 Fibrin Sealant (Human) Growth Drivers 9.3 Fibrin Sealant (Human) Market Challenges 9.4 Fibrin Sealant (Human) Market Restraints 10 Global Market Forecast 10.1 Fibrin Sealant (Human) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Fibrin Sealant (Human) by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Fibrin Sealant (Human) by Type (2022-2027) 10.2 Fibrin Sealant (Human) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Fibrin Sealant (Human) by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Fibrin Sealant (Human) by Application (2022-2027) 10.3 Fibrin Sealant (Human) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Fibrin Sealant (Human) by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Fibrin Sealant (Human) by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Fibrin Sealant (Human) Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Fibrin Sealant (Human) Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Fibrin Sealant (Human) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Fibrin Sealant (Human) Covered in This Study Table 5. Global Fibrin Sealant (Human) Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Fibrin Sealant (Human) Sales Share by Manufacturers (2016-2021) Table 7. Global Fibrin Sealant (Human) Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Fibrin Sealant (Human) Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Fibrin Sealant (Human) Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Fibrin Sealant (Human) Manufacturing Sites and Area Served Table 11. Manufacturers Fibrin Sealant (Human) Product Type Table 12. Global Fibrin Sealant (Human) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Fibrin Sealant (Human) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibrin Sealant (Human) as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Fibrin Sealant (Human) Sales by Region (2016-2021) & (K MT) Table 16. Global Fibrin Sealant (Human) Sales Market Share by Region (2016-2021) Table 17. Global Fibrin Sealant (Human) Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Fibrin Sealant (Human) Sales by Country (2016-2021) & (K MT) Table 19. North America Fibrin Sealant (Human) Sales Market Share by Country (2016-2021) Table 20. North America Fibrin Sealant (Human) Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Fibrin Sealant (Human) Revenue Market Share by Country (2016-2021) Table 22. Europe Fibrin Sealant (Human) Sales by Country (2016-2021) & (K MT) Table 23. Europe Fibrin Sealant (Human) Sales Market Share by Country (2016-2021) Table 24. Europe Fibrin Sealant (Human) Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Fibrin Sealant (Human) Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Fibrin Sealant (Human) Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Fibrin Sealant (Human) Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Fibrin Sealant (Human) Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Fibrin Sealant (Human) Revenue Market Share by Region (2016-2021) Table 30. Latin America Fibrin Sealant (Human) Sales by Country (2016-2021) & (K MT) Table 31. Latin America Fibrin Sealant (Human) Sales Market Share by Country (2016-2021) Table 32. Latin America Fibrin Sealant (Human) Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Fibrin Sealant (Human) Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Fibrin Sealant (Human) Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Fibrin Sealant (Human) Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Fibrin Sealant (Human) Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Fibrin Sealant (Human) Revenue Market Share by Country (2016-2021) Table 38. Global Fibrin Sealant (Human) Sales (K MT) by Type (2016-2021) Table 39. Global Fibrin Sealant (Human) Sales Market Share by Type (2016-2021) Table 40. Global Fibrin Sealant (Human) Revenue (Million US$) by Type (2016-2021) Table 41. Global Fibrin Sealant (Human) Revenue Share by Type (2016-2021) Table 42. Global Fibrin Sealant (Human) Price (USD/MT) by Type (2016-2021) Table 43. Global Fibrin Sealant (Human) Sales (K MT) by Application (2016-2021) Table 44. Global Fibrin Sealant (Human) Sales Market Share by Application (2016-2021) Table 45. Global Fibrin Sealant (Human) Revenue (Million US$) by Application (2016-2021) Table 46. Global Fibrin Sealant (Human) Revenue Share by Application (2016-2021) Table 47. Global Fibrin Sealant (Human) Price (USD/MT) by Application (2016-2021) Table 48. Baxter Corporation Information Table 49. Baxter Description and Business Overview Table 50. Baxter Fibrin Sealant (Human) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. Baxter Fibrin Sealant (Human) Product Table 52. Baxter Recent Developments/Updates Table 53. CSL Corporation Information Table 54. CSL Description and Business Overview Table 55. CSL Fibrin Sealant (Human) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. CSL Fibrin Sealant (Human) Product Table 57. CSL Recent Developments/Updates Table 58. Bayer Corporation Information Table 59. Bayer Description and Business Overview Table 60. Bayer Fibrin Sealant (Human) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Bayer Fibrin Sealant (Human) Product Table 62. Bayer Recent Developments/Updates Table 63. Grifols Corporation Information Table 64. Grifols Description and Business Overview Table 65. Grifols Fibrin Sealant (Human) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Grifols Fibrin Sealant (Human) Product Table 67. Grifols Recent Developments/Updates Table 68. Octapharma Corporation Information Table 69. Octapharma Description and Business Overview Table 70. Octapharma Fibrin Sealant (Human) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Octapharma Fibrin Sealant (Human) Product Table 72. Octapharma Recent Developments/Updates Table 73. Shanghai RAAS Corporation Information Table 74. Shanghai RAAS Description and Business Overview Table 75. Shanghai RAAS Fibrin Sealant (Human) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Shanghai RAAS Fibrin Sealant (Human) Product Table 77. Shanghai RAAS Recent Developments/Updates Table 78. Hualan Biological Corporation Information Table 79. Hualan Biological Description and Business Overview Table 80. Hualan Biological Fibrin Sealant (Human) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. Hualan Biological Fibrin Sealant (Human) Product Table 82. Hualan Biological Recent Developments/Updates Table 83. Immuno Corporation Information Table 84. Immuno Description and Business Overview Table 85. Immuno Fibrin Sealant (Human) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. Immuno Fibrin Sealant (Human) Product Table 87. Immuno Recent Developments/Updates Table 88. Behringwerke Corporation Information Table 89. Behringwerke Description and Business Overview Table 90. Behringwerke Fibrin Sealant (Human) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 91. Behringwerke Fibrin Sealant (Human) Product Table 92. Behringwerke Recent Developments/Updates Table 93. Production Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Fibrin Sealant (Human) Distributors List Table 96. Fibrin Sealant (Human) Customers List Table 97. Fibrin Sealant (Human) Market Trends Table 98. Fibrin Sealant (Human) Growth Drivers Table 99. Fibrin Sealant (Human) Market Restraints Table 100. Global Fibrin Sealant (Human) Sales Forecast by Type (2022-2027) & (K MT) Table 101. Global Fibrin Sealant (Human) Sales Market Share Forecast by Type (2022-2027) Table 102. Global Fibrin Sealant (Human) Revenue Forecast by Type (2022-2027) & (US$ Million) Table 103. Global Fibrin Sealant (Human) Revenue Market Share Forecast by Type (2022-2027) Table 104. Global Fibrin Sealant (Human) Sales Forecast by Application (2022-2027) & (K MT) Table 105. Global Fibrin Sealant (Human) Sales Market Share Forecast by Application (2022-2027) Table 106. Global Fibrin Sealant (Human) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 107. Global Fibrin Sealant (Human) Revenue Market Share Forecast by Application (2022-2027) Table 108. Global Fibrin Sealant (Human) Sales Forecast by Region (2022-2027) & (K MT) Table 109. Global Fibrin Sealant (Human) Sales Market Share Forecast by Region (2022-2027) Table 110. Global Fibrin Sealant (Human) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 111. Global Fibrin Sealant (Human) Revenue Market Share Forecast by Region (2022-2027) Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Fibrin Sealant (Human) Figure 2. Global Fibrin Sealant (Human) Market Share by Type in 2020 & 2027 Figure 3. 2mL/Set Product Picture Figure 4. 4mL/Set Product Picture Figure 5. 10mL/Set Product Picture Figure 6. Global Fibrin Sealant (Human) Market Share by Application in 2020 & 2027 Figure 7. Hospital Figure 8. Clinic Figure 9. Other Figure 10. Global Fibrin Sealant (Human) Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Fibrin Sealant (Human) Market Size 2016-2027 (US$ Million) Figure 12. Global Fibrin Sealant (Human) Sales 2016-2027 (K MT) Figure 13. Global Fibrin Sealant (Human) Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Fibrin Sealant (Human) Sales Share by Manufacturers in 2020 Figure 15. Global Fibrin Sealant (Human) Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Fibrin Sealant (Human) Players: Market Share by Revenue in 2020 Figure 17. Fibrin Sealant (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Fibrin Sealant (Human) Sales Market Share by Region (2016-2021) Figure 19. Global Fibrin Sealant (Human) Sales Market Share by Region in 2020 Figure 20. Global Fibrin Sealant (Human) Revenue Market Share by Region (2016-2021) Figure 21. Global Fibrin Sealant (Human) Revenue Market Share by Region in 2020 Figure 22. U.S. Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Fibrin Sealant (Human) Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Fibrin Sealant (Human) by Type (2016-2021) Figure 47. Sales Market Share of Fibrin Sealant (Human) by Application (2016-2021) Figure 48. Sales Market Share of Fibrin Sealant (Human) by Application in 2020 Figure 49. Revenue Share of Fibrin Sealant (Human) by Application (2016-2021) Figure 50. Revenue Share of Fibrin Sealant (Human) by Application in 2020 Figure 51. Manufacturing Cost Structure of Fibrin Sealant (Human) Figure 52. Manufacturing Process Analysis of Fibrin Sealant (Human) Figure 53. Fibrin Sealant (Human) Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological Immuno Behringwerke